Alerts will be sent to your verified email
Verify Email
BPLPHARMA
|
Bharat Parenterals
|
Kwality Pharma
|
Wanbury
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceutical Sector
|
|||
|
R&D as a % of Total Sales
|
0.41 % | n/a | n/a |
|
Financials
|
|||
|
5 yr Average ROE
|
12.73 % | 25.87 % | -30.56 % |
|
5yr average Equity Multiplier
|
1.76 | 2.2 | -3.1 |
|
5yr Average Asset Turnover Ratio
|
0.86 | 1.09 | 1.51 |
|
5yr Avg Net Profit Margin
|
8.73 % | 10.7 % | 7.58 % |
|
Price to Book
|
2.65 | 3.09 | 20.31 |
|
P/E
|
0.0 | 25.08 | 17.94 |
|
5yr Avg Cash Conversion Cycle
|
122.06 Days | 46.51 Days | -119.82 Days |
|
Inventory Days
|
46.56 Days | 59.9 Days | 20.62 Days |
|
Days Receivable
|
179.99 Days | 110.56 Days | 49.78 Days |
|
Days Payable
|
95.97 Days | 112.27 Days | 205.91 Days |
|
5yr Average Interest Coverage Ratio
|
22.68 | 15.91 | 2.36 |
|
5yr Avg ROCE
|
16.02 % | 34.24 % | -51.74 % |
|
5yr Avg Operating Profit Margin
|
11.16 % | 20.92 % | 4.22 % |
|
5 yr average Debt to Equity
|
0.26 | 0.52 | -0.61 |
|
5yr CAGR Net Profit
|
-9.67 % | 23.39 % | -2.79 % |
|
5yr Average Return on Assets
|
8.0 % | 12.43 % | 11.1 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
67.2 % | 54.83 % | 39.76 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 76.74 % |
|
Change in Promoter Holding (3 Yrs)
|
-6.64 % | 0.4 % | -0.13 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Bharat Parenterals
|
Kwality Pharma
|
Wanbury
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
-
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|